Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate

Journal of Infectious Diseases

Volumn 181, Issue 2, 2000, Pages 653-658

  Paoletti, Lawrence C ^a,d   Pinel, Julieanne ^a   Kennedy, Ronald C ^c   Kasper, Dennis L ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; STREPTOCOCCUS VACCINE;

ADOLESCENT; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BABOON; CONTROLLED STUDY; FEMALE; IMMUNOREACTIVITY; MATERNAL SERUM; MOUSE; NEWBORN; NONHUMAN; PLACENTAL TRANSFER; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; FEMALE; IMMUNITY, MATERNALLY-ACQUIRED; MICE; PAPIO; PREGNANCY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 0034049542     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315285     Document Type: Article

References (31)

1. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998; 11:497-513.
2. Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus. N Engl J Med 1988; 319:1180-220.
3. Lagergard T, Shiloach J, Robbins JB, Schneerson R. Synthesis and immunological properties of conjugates composed of group B Streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid. Infect Immun 1990; 58:687-94.
4. Madoff LC, Paoletti LC, Tai JY, Kasper DL. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J Clin Invest 1994; 94:286-92.
5. Paoletti LC, Wessels MR, Rodewald AK, Shroff AA, Jennings HJ, Kasper DL. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1994; 62:3236-43.
6. Paoletti LC, Pinel J, Johnson KD, Reinap B. Ross RA, Kasper DL. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII. J Infect Dis 1999; 180:892-5.
7. Baker CJ, Paoletti LC, Wessels MR, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999; 179:142-50.
8. Kasper DL, Paoletti LC, Wessels MR, et al. Immune response to type III group B streptococcal polysaccharide tetanus toxoid conjugate vaccine. J Clin Invest 1996; 98:2308-14.
9. Onderdonk AO, Kennedy RC. Use of animals for vaccine development. In: Paoletti LC, McInnes PM, eds. Vaccines: from concept to clinic. A guide to the development and clinical testing of vaccines for human use. Boca Raton, FL: CRC Press, 1999: 19-42.
10. Wessels MR, Paoletti LC, Rodewald AK, et al. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1993; 61:4760-6.
11. Wessels MR, Paoletti LC, Kasper DL, et al. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J Clin Invest 1990; 86:1428-33.
12. Madoff LC, Michel JL, Gong EW, Rodewald AK, Kasper DL. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect Immun 1992; 60:4989-94.
13. Rodewald AK, Onderdonk AB, Warren HB, Kasper DL. Neonatal mouse model of group B streptococcal infection. J Infect Dis 1992; 166:635-9.
14. Paoletti LC, Pinel J, Rodewald AK, Kasper DL. Therapeutic potential of human antisera to group B streptococcal glycoconjugate vaccines in neonatal mice. J Infect Dis 1997; 175:1237-9.
15. Shearer MH, Lucus AH, Anderson PW, et al. The baboon as a nonhuman primate model for assessing the effects of maternal immunization with Haemophilus influenzae type b polysaccharide vaccines. Infect Immun 1997; 65:3267-70.
16. Kim KH, Park MK, Peeters CC, et al. Comparison of nonhuman primate antibodies against Haemophilus influenzae type b polysaccharide with human antibodies in oligoclonality and in vivo protective potency. Infect Immun 1994; 62:2426-31.
17. Paoletti LC, Kennedy RC, Chanh TC, Kasper DL. Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons. Infect Immun 1996; 64:677-9.
18. Watts AM, Stanley JR, Shearer MH, Hefty PS, Kennedy RC. Fetal immunization of baboons induces a fetal-specific antibody response. Nat Med 1999; 5:427-30.
19. Guttormsen HK, Baker CJ, Edwards MS, Paoletti LC, Kasper DL. Quantitative determination of antibodies to type III group B streptococcal polysaccharide. J Infect Dis 1996; 173:142-50.
20. Baker CJ, Kasper DL, Tager IB, et al. Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest 1977; 59:810-8.
21. Wessels MR, Paoletti LC, Guttormsen HK, Michon F, D'Ambra AJ, Kasper DL. Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy. Infect Immun 1998; 66:2186-92.
22. Baker CJ, Kasper DL. Identification of sialic acid in polysaccharide antigens in group B Streptococcus. Infect Immun 1976; 13:284-8.
23. Glezen WP, Alpers M. Maternal immunization. Clin Infect Dis 1999; 28:219-24.
24. Guttormsen HK, Wetzler LM, Finberg RW, Kasper DL. Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model. Infect Immun 1998; 66:2026-32.
25. Fattom A, Li X, Cho YH, et al. Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides. Vaccine 1995; 13:1288-93.
26. Peeters CC, Tenbergen-Meekes AM, Poolman JT, Beurret M, Zegers BJM, Rijkers GT. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect Immun 1991; 59:3504-10.
27. Peeters CC, Tenbergen-Meekes AM, Evenberg DE, Poolman JT, Zegers BJ, Rijkers GT. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice. J Imniunol 1991; 146:4308-14.
28. Simister NE. Human placental Fc receptors and the trapping of immune complexes. Vaccine 1998; 16:1451-5.
29. Mulholland K, Suara RO, Siber G, et al. Maternal immunization with Haemophilus influenzae type b polysaccharide tetanus protein conjugate vaccine in the Gambia. JAMA 1996; 275:1182-8.
30. Englund J, Mbawuike I, Hammill H, Holleman M, Baxter B, Glezen W. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody production in young infants, J Infect Dis 1993; 168:647-56.
31. Englund JA, Glezen WP, Turner C, Harvey J, Thompson C, Siber G. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines. J Infect Dis 1995; 171:99-105.